Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Am J Clin Oncol. 2018 Sep;41(9):874–881. doi: 10.1097/COC.0000000000000388

Table 2.

Subgroup analysis of obese participants and normal-BMI participants with hepatocellular cancer (HCC)

Subgroups Categories No. of studies Obese vs Normal
HR (95% CI) Pinteraction
Location Asia-Pacific 1 2.10 (1.77–2.48) .03
Western 4 1.10 (0.63–1.92)
Sex Males 3 2.50 (2.02–3.09) .004
Females 2 1.45 (1.08–1.97)
Adjusted for alcohol Yes 3 1.77 (1.21–2.57) .19
No 2 2.82 (1.56–5.11)
Adjusted for diabetes mellitus Yes 2 2.82 (1.56–5.11) .19
No 3 1.77 (1.21–2.57)